Tuñacao, Gomersendo B.
HRN: 21-84-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/24/2022
08/30/2022
IVT
600mg
Q8
Lung Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes